BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CALL
General Dynamics
GD
$106B
| $110K | ﹤0.01% |
6
| – | – |
|
2952
Quanex
NX
$981M
| $109K | ﹤0.01% |
6,046
+1,581
| +35% | +$28.4K |
|
2953
CALL
Capital One
COF
$137B
| $109K | ﹤0.01% |
12
| – | – |
|
|
CWEN.A
2954
DELISTED
Clearway Energy Class A
CWEN.A
| $109K | ﹤0.01% |
6,295
-135
| -2% | -$2.28K |
|
|
TVRD
2955
Tvardi Therapeutics
TVRD
$22.1M
| $109K | ﹤0.01% |
165
+64
| +63% | +$53.2K |
|
2956
Vanda Pharmaceuticals
VNDA
$304M
| $109K | ﹤0.01% |
8,192
+2,458
| +43% | +$34.3K |
|
|
GOOD
2957
Gladstone Commercial Corp
GOOD
$641M
| $108K | ﹤0.01% |
4,616
+559
| +14% | +$12.4K |
|
|
MODV
2958
DELISTED
ModivCare
MODV
| $108K | ﹤0.01% |
1,815
+317
| +21% | +$18.1K |
|
|
RTLR
2959
DELISTED
Rattler Midstream LP Common Units
RTLR
| $108K | ﹤0.01% |
6,048
-4,453
| -42% | -$82.4K |
|
2960
Harmony Gold Mining
HMY
$12B
| $108K | ﹤0.01% |
37,943
-22,472
| -37% | -$65.8K |
|
2961
National CineMedia
NCMI
$252M
| $107K | ﹤0.01% |
1,308
-379
| -22% | -$28.3K |
|
2962
St. Joe Company
JOE
$3.89B
| $107K | ﹤0.01% |
6,239
-92
| -1% | -$1.63K |
|
2963
Ecovyst
ECVT
$1.1B
| $107K | ﹤0.01% |
6,703
-372
| -5% | -$5.69K |
|
|
GNC
2964
DELISTED
GNC Holdings, Inc.
GNC
| $106K | ﹤0.01% |
49,718
-1,098
| -2% | -$2.2K |
|
2965
Community Trust Bancorp
CTBI
$1.44B
| $106K | ﹤0.01% |
2,497
-378
| -13% | -$15.5K |
|
|
FFG
2966
DELISTED
FBL Financial Group
FFG
| $106K | ﹤0.01% |
1,786
-264
| -13% | -$15.8K |
|
2967
Camden National
CAC
$996M
| $106K | ﹤0.01% |
2,443
-198
| -7% | -$8.59K |
|
2968
iShares US Healthcare ETF
IYH
$3.77B
| $106K | ﹤0.01% |
2,795
-5,775
| -67% | -$222K |
|
2969
Vericel Corp
VCEL
$2.28B
| $105K | ﹤0.01% |
6,940
+2,077
| +43% | +$36.3K |
|
2970
Alpha Metallurgical Resources
AMR
$1.97B
| $105K | ﹤0.01% |
3,755
+2,413
| +180% | +$83.9K |
|
2971
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$723M
| $105K | ﹤0.01% |
2,374
-1,833
| -44% | -$83.1K |
|
2972
ADT
ADT
$5.46B
| $104K | ﹤0.01% |
16,650
-6,847
| -29% | -$38.8K |
|
2973
Nutrien
NTR
$32.2B
| $104K | ﹤0.01% |
2,091
| – | – |
|
2974
Koppers
KOP
$874M
| $104K | ﹤0.01% |
3,565
+278
| +8% | +$7.71K |
|
|
RESI
2975
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $104K | ﹤0.01% |
9,006
+409
| +5% | +$4.73K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.